# High Doses of 4-aminopyridine in Clinically Complete Chronic Spinal Cord Injury Patients.

> **NCT03899584** · PHASE3 · UNKNOWN · sponsor: **Coordinación de Investigación en Salud, Mexico** · enrollment: 150 (actual)

## Conditions studied

- Spinal Cord Injuries
- Chronic

## Interventions

- **DRUG:** 4-Aminopyridine
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03899584
- **Lead sponsor:** Coordinación de Investigación en Salud, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-17
- **Primary completion:** 2022-12
- **Final completion:** 2023-12
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03899584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03899584, "High Doses of 4-aminopyridine in Clinically Complete Chronic Spinal Cord Injury Patients.". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03899584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*